Pharma and Biotech Industry Visit US 2025
Join us for a market visit to the U.S. pharmaceutical industry & position yourselves as supplier or technology partner to some of the industry’s leading players.
Time
20.05.2025 - 22.05.2025
Dates to be confirmed
Location
USA, New Jersey
Price
We are applying for grants from the Trade Council of Denmark and the participation price will be based on whether we receive co-funding.
We are pleased to invite your company to participate in a market visit to the U.S. pharmaceutical industry, taking place from 19 – 23 May 2025 (dates to be finally confirmed). This initiative offers a unique opportunity for Danish companies to gain direct insight into the world’s largest pharmaceutical market and position themselves as suppliers or technology partners to some of the industry’s leading players.
The 4-5 day program includes visits to top pharmaceutical manufacturers in the and around Philadelphia, with potential meetings at companies such as Janssen Pharmaceuticals, Merck, Bristol Myers Squibb, and Johnson & Johnson. These visits provide participants with the opportunity to meet key decision-makers, gain insights into upcoming projects and production upgrades, and present your solutions directly to industry leaders. The program will coincide with the CPHI event in Philadelphia on 20-22 May 2025.
The visit is organized in collaboration with the Trade Council’s life science industry advisors in the U.S. Additionally, there will be individual meetings with relevant pharmaceutical industry associations in the U.S. A market preparation workshop will also be held to ensure that participants are well-prepared for the visit.
Who Should Participate?
This initiative is ideal for Danish companies that provide technology, process equipment, or sustainable solutions for the pharmaceutical industry. It is a unique chance to establish new export opportunities in a lucrative and continuously growing market.
Why Participate?
- Direct access to key companies in the U.S. pharmaceutical sector.
- Opportunity to present your solutions to decision-makers.
- Insights into current and future projects related to production modernization.
- Increased visibility and networking in the U.S. market.
Experience shows that joint market visits can open doors that are otherwise difficult to access in this highly regulated industry. We hope you will seize the opportunity to participate in this first-ever Danish initiative targeting the U.S. pharmaceutical industry.
If you are interested in participating or would like more information about the program, please contact Thomas Andersen.
-
Thomas Andersen
Head of Health Tech+45 2447 8502 tan@danishexport.dk
Thomas Andersen
Head of Health Tech
Thomas har et stort kendskab til life science-industrien samt sundheds- og velfærdssektoren, og vil du have sparring på, hvordan du kan øge din eksport i disse sektorer, er det ham, du skal tage fat i. Han er primus motor i vores Health Tech-netværk, og med mere end 20 års eksporterfaring har han blandt andet stort kendskab til markedsetablering.
Thomas har arbejdet i både private virksomheder og den offentlige sektor. Han har også været selvstændig i tre år, og derfor har han hands-on viden om de udfordringer, mindre virksomheder står med, når de skal øge deres eksport.
Vil du have sparring på markeder, kan Thomas hjælpe dig med viden om de fleste europæiske lande samt Australien, Kenya og Thailand, hvor han har været udstationeret.
This event is subsidised by The Trade Council. To participate with subsidy, your company must be eligible to receive subsidies based on the de-minimis-rules and regulations from the Trade Council.
The de minimis-enactment means that a company can receive public subsidies of maximum EUR 300,000 within a period of three years. To receive subsidies, companies must be registered with a Danish VAT-number and complete a business form.